{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:39:55Z","timestamp":1777257595671,"version":"3.51.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Primary aldosteronism (PA) screening is difficult in an unselected population of hypertensive patients, as it can be challenging. We report new algorithms based either on risk stratification or machine learning models to improve the screening of PA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>15,507 patients with confirmed hypertension aged 18\u201365 years with full workup for PA screening were included in this study. We developed PAstrat, a risk stratification-based algorithm by generating patient groups of interest and assess probability of PA in each group, and two different machine learning models, logistic regression and XGBoost. An external cohort of 768 patients was used for validation. The AUC of the ROC curves for the PAstrat algorithm, logistic regression, and XGboost were, respectively, 0.80, 0.82, and 0.83 in the derivation cohort and 0.79, 0.82, and 0.82 in the validation cohort. Only 0.7% of the population (6 of 768) or 4.2% of patients with PA (6 of 142) had PA despite incorrect prediction by PAstrat (negative predictive value, 0.96). Conversely, among the 128 patients who had an indication for PA screening based on age, kalaemia, or drug resistance but not according to the algorithm, only 3 (0.23%) patients had PA. Logistic regression and XGBoost had, respectively, 49 (6.7%) and 84 (10.9%) false negatives (negative predictive value, respectively, 0.87 and 0.88).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We developed a risk stratification algorithm for PA screening and compared its performances to machine learning models. Our algorithm demonstrated good sensitivity and negative predictive value for the screening of secondary hypertension, with the added value of great interpretability. Machine learning models lacked explainability and demonstrated a lower negative value in the validation cohort which makes them less easily usable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwag197","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:19:44Z","timestamp":1775474384000},"source":"Crossref","is-referenced-by-count":0,"title":["Predicting primary aldosteronism: risk stratification-based and machine learning-based models"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3829-9506","authenticated-orcid":false,"given":"Jean-Baptiste","family":"de Freminville","sequence":"first","affiliation":[{"name":"Hypertension Unit, Vascular Medicine Department, Universit\u00e9 Paris-Cit\u00e9, AP-HP, H\u00f4pital Europ\u00e9en Georges Pompidou, Trousseau Universitary Hospital , Paris, Chambray-l\u00e8s-Tours 37170 ,","place":["France"]},{"name":"Centre de Recherche des Cordeliers, Universit\u00e9 Paris Cit\u00e9, Inserm, Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"INSERM UMR1327, ISCHEMIA, Universit\u00e9 de Tours , Tours ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3942-4276","authenticated-orcid":false,"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Vascular Medicine Department, Universit\u00e9 Paris-Cit\u00e9, AP-HP, H\u00f4pital Europ\u00e9en Georges Pompidou, Trousseau Universitary Hospital , Paris, Chambray-l\u00e8s-Tours 37170 ,","place":["France"]},{"name":"Adrenal Referral Center, Universit\u00e9 Paris Cit\u00e9, AP-HP , Paris ,","place":["France"]},{"name":"Inserm Paris Cardiovascular Research Center , Universit\u00e9 Paris-Cit\u00e9, Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-563X","authenticated-orcid":false,"given":"Jean","family":"Feydy","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Universit\u00e9 Paris Cit\u00e9, Inserm, Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"HeKA Team INRIA, INSERM, Universit\u00e9 Paris-Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6197-5766","authenticated-orcid":false,"given":"Antoine","family":"Cremer","sequence":"additional","affiliation":[{"name":"Hypertension Excellence Center, University Hospital of Bordeaux, Hopital Saint Andr\u00e9 , Bordeaux ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4157-6535","authenticated-orcid":false,"given":"Romain","family":"Boulestreau","sequence":"additional","affiliation":[{"name":"Coronary and Vascular Disease Department, CHU de Bordeaux , Bordeaux ,","place":["France"]},{"name":"UMR INSERM U1034, Universit\u00e9 de Bordeaux , Bordeaux ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5840-7749","authenticated-orcid":false,"given":"Philippe","family":"Gosse","sequence":"additional","affiliation":[{"name":"Hypertension Excellence Center, University Hospital of Bordeaux, Hopital Saint Andr\u00e9 , Bordeaux ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phanie","family":"Baron","sequence":"additional","affiliation":[{"name":"Physiology Department, AP-HP, H\u00f4pital Europ\u00e9en Georges Pompidou, Universit\u00e9 Paris-Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0597-8318","authenticated-orcid":false,"given":"Michel","family":"Azizi","sequence":"additional","affiliation":[{"name":"Hypertension Unit, Vascular Medicine Department, Universit\u00e9 Paris-Cit\u00e9, AP-HP, H\u00f4pital Europ\u00e9en Georges Pompidou, Trousseau Universitary Hospital , Paris, Chambray-l\u00e8s-Tours 37170 ,","place":["France"]},{"name":"Inserm Paris Cardiovascular Research Center , Universit\u00e9 Paris-Cit\u00e9, Paris ,","place":["France"]},{"name":"Inserm CIC 1418 , Universit\u00e9 Paris-Cit\u00e9, Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4417-1197","authenticated-orcid":false,"given":"Bastien","family":"Rance","sequence":"additional","affiliation":[{"name":"Centre de Recherche des Cordeliers, Universit\u00e9 Paris Cit\u00e9, Inserm, Sorbonne Universit\u00e9 , Paris ,","place":["France"]},{"name":"Medical Informatics, Biostatistics and Public Health Department, AP-HP, H\u00f4pital Europ\u00e9en Georges Pompidou, Universit\u00e9 Paris-Cit\u00e9 , Paris ,","place":["France"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"2026042622235724700_zwag197-B1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026042622235724700_zwag197-B2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/ndt\/gfh112","article-title":"Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension","volume":"19","author":"Plouin","year":"2004","journal-title":"Nephrol Dial Transpl"},{"key":"2026042622235724700_zwag197-B3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026042622235724700_zwag197-B4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1055\/s-0043-119755","article-title":"Is primary aldosteronism still largely unrecognized?","volume":"49","author":"Buffolo","year":"2017","journal-title":"Horm Metab Res"},{"key":"2026042622235724700_zwag197-B5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"2026042622235724700_zwag197-B6","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"2026042622235724700_zwag197-B7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1097\/HJH.0000000000002441","article-title":"Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension","volume":"38","author":"Parasiliti-Caprino","year":"2020","journal-title":"J Hypertens"},{"key":"2026042622235724700_zwag197-B8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026042622235724700_zwag197-B9","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2026042622235724700_zwag197-B10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"2026042622235724700_zwag197-B11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026042622235724700_zwag197-B12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","volume":"113","author":"Marney","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"2026042622235724700_zwag197-B13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ando.2016.05.001","article-title":"SFE\/SFHTA\/AFCE primary aldosteronism consensus: introduction and handbook","volume":"77","author":"Amar","year":"2016","journal-title":"Annales d\u2019Endocrinologie"},{"key":"2026042622235724700_zwag197-B14","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/s41440-023-01461-1","article-title":"Endocrine causes of hypertension: literature review and practical approach","volume":"46","author":"de Freminville","year":"2023","journal-title":"Hypertens Res"},{"key":"2026042622235724700_zwag197-B15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026042622235724700_zwag197-B16","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the European society of hypertension \u2217","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"2026042622235724700_zwag197-B17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12020-021-02745-7","article-title":"Development and validation of a novel diagnostic nomogram model to predict primary aldosteronism in patients with hypertension","volume":"73","author":"Wang","year":"2021","journal-title":"Endocrine"},{"key":"2026042622235724700_zwag197-B18","doi-asserted-by":"crossref","first-page":"e0272049","DOI":"10.1371\/journal.pone.0272049","article-title":"Clinical and biochemical predictors and predictive model of primary aldosteronism","volume":"17","author":"Manosroi","year":"2022","journal-title":"PLoS One"},{"key":"2026042622235724700_zwag197-B19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.surg.2023.04.063","article-title":"Development of a risk-prediction model for primary aldosteronism in veterans with hypertension","volume":"175","author":"Ginzberg","year":"2024","journal-title":"Surgery"},{"key":"2026042622235724700_zwag197-B20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/HYPERTENSIONAHA.121.17444","article-title":"Clinical score and machine learning-based model to predict diagnosis of primary aldosteronism in arterial hypertension","volume":"78","author":"Buffolo","year":"2021","journal-title":"Hypertension"},{"key":"2026042622235724700_zwag197-B21","doi-asserted-by":"crossref","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD + AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"2026042622235724700_zwag197-B22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026042622235724700_zwag197-B23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/HYPERTENSIONAHA.116.07214","article-title":"Suppression of aldosterone secretion after recumbent saline infusion does not exclude lateralized primary aldosteronism","volume":"68","author":"Cornu","year":"2016","journal-title":"Hypertension"},{"key":"2026042622235724700_zwag197-B24","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/HJH.0000000000001735","article-title":"Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration","volume":"36","author":"Baron","year":"2018","journal-title":"J Hypertens"},{"key":"2026042622235724700_zwag197-B25","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European society of hypertension endorsed by the European renal association (ERA) and the international society of hypertension (ISH)","volume":"41","author":"Mancia Chairperson","year":"2023","journal-title":"J Hypertens"},{"key":"2026042622235724700_zwag197-B26","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO)","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"key":"2026042622235724700_zwag197-B27","first-page":"808","article-title":"[Testing an expert system for hypertension]","volume":"79","author":"Jeunemaitre","year":"1986","journal-title":"Arch Mal Coeur Vaiss"},{"key":"2026042622235724700_zwag197-B28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ajh\/3.2.156","article-title":"Computer-assisted techniques for evaluation and treatment of hypertensive patients","volume":"3","author":"Degoulet","year":"1990","journal-title":"Am J Hypertens"},{"key":"2026042622235724700_zwag197-B29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1386-5056(02)00101-6","article-title":"The HEGP component-based clinical information system","volume":"69","author":"Degoulet","year":"2003","journal-title":"Int J Med Inform"},{"key":"2026042622235724700_zwag197-B30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00004872-200018040-00006","article-title":"Comparison of nurse- and physician-determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management","volume":"18","author":"La Batide-Alanore","year":"2000","journal-title":"J Hypertens"},{"key":"2026042622235724700_zwag197-B31","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCRESAHA.121.318106","article-title":"Artificial intelligence in hypertension: seeing through a glass darkly","volume":"128","author":"Padmanabhan","year":"2021","journal-title":"Circ Res"},{"key":"2026042622235724700_zwag197-B32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41512-018-0037-2","article-title":"Quantifying the added value of new biomarkers: how and how not","volume":"2","author":"Cook","year":"2018","journal-title":"Diagn Progn Res"},{"key":"2026042622235724700_zwag197-B33","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1001\/jama.2021.22396","article-title":"Next-generation artificial intelligence for diagnosis: from predicting diagnostic labels to \u201cwayfinding\u201d","volume":"326","author":"Adler-Milstein","year":"2021","journal-title":"JAMA"},{"key":"2026042622235724700_zwag197-B34","doi-asserted-by":"crossref","first-page":"e745","DOI":"10.1016\/S2589-7500(21)00208-9","article-title":"The false hope of current approaches to explainable artificial intelligence in health care","volume":"3","author":"Ghassemi","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2026042622235724700_zwag197-B35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11019-022-10076-1","article-title":"The deception of certainty: how non-interpretable machine learning outcomes challenge the epistemic authority of physicians. A deliberative-relational approach","volume":"25","author":"Funer","year":"2022","journal-title":"Med Health Care Philos"},{"key":"2026042622235724700_zwag197-B36","doi-asserted-by":"crossref","first-page":"e19739","DOI":"10.2196\/19739","article-title":"An application of machine learning to etiological diagnosis of secondary hypertension: retrospective study using electronic medical records","volume":"9","author":"Diao","year":"2021","journal-title":"JMIR Med Inform"},{"key":"2026042622235724700_zwag197-B37","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/HJH.0000000000001511","article-title":"Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K","volume":"36","author":"Yamashita","year":"2018","journal-title":"J Hypertens"},{"key":"2026042622235724700_zwag197-B38","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/cen.14142","article-title":"Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism","volume":"92","author":"Kietsiriroje","year":"2020","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwag197\/68161510\/zwag197.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwag197\/68161510\/zwag197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T02:24:06Z","timestamp":1777256646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article\/doi\/10.1093\/eurjpc\/zwag197\/8662741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":38,"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwag197","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"article-number":"zwag197"}}